February 11, 2019

IntegriChain to Present at Baird’s 4th Annual Private Company Technology & Services Conference

Philadelphia, PA, February 11, 2019 – IntegriChain, a leading life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence, today announced that IntegriChain’s Executive Vice President, Joshua Halpern, will present a company overview at Baird’s 4th Annual Private Company Technology & Services Conference. Halpern’s presentation will take place on Wednesday, February 13, at the Mandarin Oriental, New York.

About IntegriChain
IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 150 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, and the company’s Access Management Operations center is in Ambler, PA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain and LinkedIn.

Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com